Furthermore, another CAIX targeting tracer (HE)3-ZCAIX:1, based on Affibody molecules, has recently been developed and tested in CAIX-expressing SK-RC-52 renal carcinoma xenografts. This evidence concerns the gene CA9 and renal carcinoma.